You are here: Industry Insights > Lilly

News List

Lilly Opens Randomized Trial in Treatment-Naïve RET Fusion-Positive NSCLC americanpharmaceuticalreview
December 17, 2019
Eli Lilly and Company announced the opening of the LIBRETTO-431 clinical trial for selpercatinib, also known as LOXO-292 ...
Tyvyt (Sintilimab Injection), an Innovative PD-1 Inhibitor Jointly Developed by Innovent and Lilly, is Included in the New Catalogue of National Reimbursement Drug List (NRDL) En-CPhI.CN
December 02, 2019
Innovent Biologics, Inc., a world-class biopharmaceutical company that develops and commercializes high quality medicines for the treatment of oncology ...
Zuellig Pharma enters into strategic partnership with Eli Lilly and Company in Malaysia and Thailand En-CPhI.CN
October 24, 2019
Zuellig Pharma, a leading healthcare service provider in Asia, is pleased to announce two new strategic partnerships with Eli Lilly and Company (Lilly) to market ...
Thermo, Lilly Enter Companion Diagnostic Pact contractpharma
September 10, 2019
Thermo retains rights to commercialize the test in all markets and will submit a supplemental premarket approval to FDA.
Lilly's Pain Clinical Trial Protocol Selected for FDA Trial Designs Pilot Meeting Program americanpharmaceuticalreview
September 09, 2019
Eli Lilly and Company announced the U.S. Food and Drug Administration (FDA) has accepted its application to enter the Complex Innovative Trial Designs (CID) Pilot Meeting Program...
Amgen's Aimovig, under fire from Lilly, loses grip on next-gen migraine share fiercepharma
September 08, 2019
Amgen had a head start with its first-to-market CGRP launch Aimovig, but its rivals are giving the company some fierce competition.
Lilly Receives FDA Approval for Ankylosing Spondylitis Treatment contractpharma
August 28, 2019
This is the third indication for Taltz, first approved for moderate to severe plaque psoriasis.
Appeals Court Rules in Favor of Lilly in Alimta Alternate Salt Form Patent Lawsuit americanpharmaceuticalreview
August 13, 2019
Eli Lilly and Company announced the U.S. Court of Appeals for the Federal Circuit ruled in favor of Lilly, confirming that the Alimta® (pemetrexed for injection) vitamin regimen patent would be infringed by competitors that ...
US court rules in favour of Lilly in Alimta® patent lawsuit europeanpharmaceuticalreview
August 13, 2019
The US District Court has ruled in favour of Eli Lilly in the Alimta patent lawsuit against Dr. Reddy’s Laboratories and Hospira, Inc.
Lilly, Evidation Health and Apple study shows personal digital devices may help in the identification of mild cognitive impairment and mild Alzheimer's disease dementia worldpharmanews
August 12, 2019
Initial results from a feasibility study conducted by Eli Lilly and Company (NYSE: LLY), Evidation Health, and Apple Inc. showed that an iPhone, Apple Watch, iPad and the Beddit sleep monitoring device...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 25 26 Next page